12-57243885-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145064.3(STAC3):c.1022C>T(p.Ala341Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_145064.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STAC3 | NM_145064.3 | c.1022C>T | p.Ala341Val | missense_variant | 12/12 | ENST00000332782.7 | NP_659501.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STAC3 | ENST00000332782.7 | c.1022C>T | p.Ala341Val | missense_variant | 12/12 | 2 | NM_145064.3 | ENSP00000329200 | P1 | |
STAC3 | ENST00000554578.5 | c.905C>T | p.Ala302Val | missense_variant | 11/11 | 1 | ENSP00000452068 | |||
STAC3 | ENST00000557176.5 | c.*82C>T | 3_prime_UTR_variant, NMD_transcript_variant | 8/8 | 1 | ENSP00000450740 | ||||
STAC3 | ENST00000546246.2 | c.464C>T | p.Ala155Val | missense_variant | 9/9 | 2 | ENSP00000441515 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250334Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135520
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461660Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 727126
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152072Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74294
ClinVar
Submissions by phenotype
Bailey-Bloch congenital myopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 341 of the STAC3 protein (p.Ala341Val). This variant is present in population databases (rs753014378, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with STAC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 851418). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STAC3 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 13, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.1022C>T (p.A341V) alteration is located in exon 12 (coding exon 11) of the STAC3 gene. This alteration results from a C to T substitution at nucleotide position 1022, causing the alanine (A) at amino acid position 341 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at